Arrowstreet Capital
PNT

Arrowstreet Capital’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Arrowstreet Capital’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-522,966
Closed -$3.49M – 1593
2023
Q3 		$3.49M Buy
522,966
+279,801
+115% +$2.33M ﹤0.01% 733
2023
Q2 		$2.2M Buy
+243,165
New +$2.14M ﹤0.01% 801

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Arrowstreet Capital's PNT Position: Q4 2023 in Review

Arrowstreet Capital sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 522,966 shares — an estimated $3.49M sold.

Arrowstreet Capital first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $3.49M in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Arrowstreet Capital reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Arrowstreet Capital sold 522,966 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $3.49M.
  • Arrowstreet Capital first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Arrowstreet Capital's POINT Biopharma Global Inc. Common Stock position peaked at $3.49M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Arrowstreet Capital's 13F filing for Q4 2023, filed 14 Feb 2024.